197331 Sigma-AldrichBcl-2 Inhibitor II, YC137 - CAS 810659-53-1 - Calbiochem
The Bcl-2 Inhibitor II, YC137, also referenced under CAS 810659-53-1, controls the biological activity of Bcl-2. This small molecule/inhibitor is primarily used for Activators/Inducers applications.
More>> The Bcl-2 Inhibitor II, YC137, also referenced under CAS 810659-53-1, controls the biological activity of Bcl-2. This small molecule/inhibitor is primarily used for Activators/Inducers applications. Less<<同義語: 2-Methoxycarbonylamino-4-methylsulfanyl-butyric acid, 4-(4,9-dioxo-4,9-dihydronaphtho[2,3-d]thiazol-2-ylamino)-phenyl ester
お勧めの製品
概要
Replacement Information |
---|
主要スペック表
CAS # | Empirical Formula |
---|---|
810659-53-1 | C₂₄H₂₁N₃O₆S₂ |
価格&在庫状況
カタログ番号 | 在庫状況 | 包装 | Qty/Pk | 価格 | 数量 | |
---|---|---|---|---|---|---|
197331-5MGCN |
|
ガラスビン | 5 mg |
|
— |
References | |
---|---|
References | Real, P.J., et al. 2004. Cancer Res. 64, 7947. |
Product Information | |
---|---|
CAS number | 810659-53-1 |
ATP Competitive | N |
Form | Red solid |
Hill Formula | C₂₄H₂₁N₃O₆S₂ |
Chemical formula | C₂₄H₂₁N₃O₆S₂ |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | Bcl-2 |
Primary Target K<sub>i</sub> | 1.3 µM in binding Bcl-2 |
Purity | ≥90% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
カタログ番号 | GTIN |
197331-5MGCN | 04055977206081 |
Documentation
Bcl-2 Inhibitor II, YC137 - CAS 810659-53-1 - Calbiochem (M)SDS
タイトル |
---|
Bcl-2 Inhibitor II, YC137 - CAS 810659-53-1 - Calbiochem 試験成績書(CoA)
タイトル | ロット番号 |
---|---|
197331 |
参考資料
参考資料の概要 |
---|
Real, P.J., et al. 2004. Cancer Res. 64, 7947. |